Search for: "PFIZER INC. V. TEVA PHARMACEUTICALS USA, INC. "
Results 21 - 40
of 70
Sorted by Relevance
|
Sort by Date
28 Jul 2010, 2:32 pm
Teva Pharmaceuticals USA, Inc., 518 F.3d 1353, 1363 (Fed. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
8 Oct 2009, 12:37 pm
Teva Pharmaceuticals USA, Inc. 518 F.3d 1353 (Fed. [read post]
14 May 2019, 11:24 am
Cir. 2009) (quoting Pfizer, Inc. v. [read post]
12 Mar 2008, 8:50 pm
USA, Inc. after the jump. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
5 May 2010, 4:46 am
Taro Pharmaceutical USA Inc. et al (Patent Docs) Viagra (Sildenafil) – Brazil patents to expire 1 year early? [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says… [read post]
24 Mar 2010, 4:45 am
Teva Pharamceuticals USA, Inc. [read post]
23 Jun 2010, 10:28 pm
Teva Pharmaceuticals USA, Inc. et al. [read post]
1 Apr 2008, 2:16 am
Teva Pharmaceuticals USA, Inc. [read post]
12 Nov 2009, 9:17 am
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186, at *2-3 (S.D. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
1 Feb 2013, 9:42 am
Pfizer, Inc., 877 F. [read post]
6 Nov 2015, 6:58 am
Therefore, it was not obvious to test pregabalin – it might be obvious to test gabapentin, but even here the judge considered that the skilled team would have little expectation of success.InsufficiencyAccording to the caselaw relating to sufficiency developed in MedImmune Ltd v Novartis Pharmaceuticals UK Ltd [2011] EWHC 1699 (Pat) at [458]-[484] and summarised in Sandvik Intellectual Property AB v Kennametal UK Ltd [2011] EWHC 3311 (Pat) at… [read post]
